Literature DB >> 19861414

Cannabinoid 1 receptor and interleukin-6 receptor together induce integration of protein kinase and transcription factor signaling to trigger neurite outgrowth.

Yana Zorina1, Ravi Iyengar, Kenneth D Bromberg.   

Abstract

Activation of the G(o/i)-coupled cannabinoid 1 receptor (CB1R) has been shown to induce neurite outgrowth in Neuro2A cells through activation of Src kinase and STAT3 transcription factor. Signaling by the interleukin 6 receptor (IL-6R) also activates STAT3 through Jak kinase. We studied if signals from the two pathways could be integrated in a synergistic manner to trigger neurite outgrowth in Neuro2A cells. At low concentrations, when agonist at either receptor by itself has no effect, we found that CB1R and IL-6R stimulation together induced synergistic neurite outgrowth. Signal integration requires activation of transcription factors by Src, Jak, and mitogen-activated protein kinases. Mitogen-activated protein kinase can be activated by both receptors and shows enhanced early activation in the presence of both ligands. CREB and STAT3 transcription factors are required for synergy and show enhanced DNA-binding activity when both receptors are activated. STAT3 plays a critical role in integration of the signals downstream of the two receptors. When both pathways are activated, STAT3 phosphorylation is sustained for 6 h. This prolonged activation of STAT3 requires deactivation of SHP2 phosphatase. Reduction of SHP2 levels by RNA interference results in greater synergy in neurite outgrowth. Simultaneous knockdown of both SHP2 and STAT3 blocks the synergistic triggering of neurite outgrowth, indicating that STAT3 is downstream of SHP2. CB1R and IL-6R co-stimulation enhanced the differentiation of rat cortical neuron primary cultures. These results provide a mechanism where multiple protein kinases and transcription factors interact to integrate signals from G protein-coupled and cytokine receptor to evoke neurite outgrowth in Neuro2A cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19861414      PMCID: PMC2801262          DOI: 10.1074/jbc.M109.049841

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  Crystal structure of the tyrosine phosphatase SHP-2.

Authors:  P Hof; S Pluskey; S Dhe-Paganon; M J Eck; S E Shoelson
Journal:  Cell       Date:  1998-02-20       Impact factor: 41.582

2.  Molecular characterization of specific interactions between SHP-2 phosphatase and JAK tyrosine kinases.

Authors:  T Yin; R Shen; G S Feng; Y C Yang
Journal:  J Biol Chem       Date:  1997-01-10       Impact factor: 5.157

Review 3.  Interleukin-6 (IL-6)--a molecule with both beneficial and destructive potentials.

Authors:  R A Gadient; U H Otten
Journal:  Prog Neurobiol       Date:  1997-08       Impact factor: 11.685

4.  Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses.

Authors:  S J Rodig; M A Meraz; J M White; P A Lampe; J K Riley; C D Arthur; K L King; K C Sheehan; L Yin; D Pennica; E M Johnson; R D Schreiber
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

5.  Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells.

Authors:  H Kim; T S Hawley; R G Hawley; H Baumann
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

6.  Identification of interleukin-6 as a factor that induces neurite outgrowth by PC12 cells primed with NGF.

Authors:  S Ihara; A Iwamatsu; T Fujiyoshi; A Komi; T Yamori; Y Fukui
Journal:  J Biochem       Date:  1996-11       Impact factor: 3.387

7.  Induction of neurite outgrowth by interleukin-6 is accompanied by activation of Stat3 signaling pathway in a variant PC12 cell (E2) line.

Authors:  Y Y Wu; R A Bradshaw
Journal:  J Biol Chem       Date:  1996-05-31       Impact factor: 5.157

8.  Regulation of reactive-oxygen-species generation in fibroblasts by Rac1.

Authors:  M Sundaresan; Z X Yu; V J Ferrans; D J Sulciner; J S Gutkind; K Irani; P J Goldschmidt-Clermont; T Finkel
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

9.  Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease.

Authors:  T Müller; D Blum-Degen; H Przuntek; W Kuhn
Journal:  Acta Neurol Scand       Date:  1998-08       Impact factor: 3.209

Review 10.  Neurotrophic factors in central nervous system trauma.

Authors:  I Mocchetti; J R Wrathall
Journal:  J Neurotrauma       Date:  1995-10       Impact factor: 5.269

View more
  20 in total

Review 1.  Molecular model of cannabis sensitivity in developing neuronal circuits.

Authors:  Erik Keimpema; Ken Mackie; Tibor Harkany
Journal:  Trends Pharmacol Sci       Date:  2011-07-13       Impact factor: 14.819

2.  Microglia priming by interleukin-6 signaling is enhanced in aged mice.

Authors:  Katherine M Garner; Ravi Amin; Rodney W Johnson; Emily J Scarlett; Michael D Burton
Journal:  J Neuroimmunol       Date:  2018-09-10       Impact factor: 3.478

3.  Endocannabinoids stimulate human melanogenesis via type-1 cannabinoid receptor.

Authors:  Mariangela Pucci; Nicoletta Pasquariello; Natalia Battista; Monia Di Tommaso; Cinzia Rapino; Filomena Fezza; Michela Zuccolo; Roland Jourdain; Alessandro Finazzi Agrò; Lionel Breton; Mauro Maccarrone
Journal:  J Biol Chem       Date:  2012-03-19       Impact factor: 5.157

Review 4.  CB1 and CB2 Receptor Pharmacology.

Authors:  Allyn C Howlett; Mary E Abood
Journal:  Adv Pharmacol       Date:  2017-06-12

5.  Differential subcellular recruitment of monoacylglycerol lipase generates spatial specificity of 2-arachidonoyl glycerol signaling during axonal pathfinding.

Authors:  Erik Keimpema; Klaudia Barabas; Yury M Morozov; Giuseppe Tortoriello; Masaaki Torii; Gary Cameron; Yuchio Yanagawa; Masahiko Watanabe; Ken Mackie; Tibor Harkany
Journal:  J Neurosci       Date:  2010-10-20       Impact factor: 6.167

6.  Neuroglobin promotes neurite outgrowth via differential binding to PTEN and Akt.

Authors:  Li Li; Qian Rong Liu; Xin Xin Xiong; Ju Mei Liu; Xiao Jing Lai; Chun Cheng; Feng Pan; Yong Chen; Shang Bin Yu; Albert Cheung Hoi Yu; Xiao Qian Chen
Journal:  Mol Neurobiol       Date:  2013-08-01       Impact factor: 5.590

7.  Can case study approaches speed implementation of the NRC report: "toxicity testing in the 21st century: a vision and a strategy?".

Authors:  Melvin E Andersen; Harvey J Clewell; Paul L Carmichael; Kim Boekelheide
Journal:  ALTEX       Date:  2011       Impact factor: 6.043

8.  Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression.

Authors:  Hyangin Kim; Lucy Chen; Grewo Lim; Backil Sung; Shuxing Wang; Michael F McCabe; Gabriel Rusanescu; Liling Yang; Yinghong Tian; Jianren Mao
Journal:  J Clin Invest       Date:  2012-07-02       Impact factor: 14.808

Review 9.  Endocannabinoids via CB₁ receptors act as neurogenic niche cues during cortical development.

Authors:  Javier Díaz-Alonso; Manuel Guzmán; Ismael Galve-Roperh
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

10.  Endocannabinoid metabolism in the prefrontal cortex in schizophrenia.

Authors:  David W Volk; Benjamin I Siegel; Christopher D Verrico; David A Lewis
Journal:  Schizophr Res       Date:  2013-04-02       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.